Company news
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) news
Whitehawk Therapeutics, Inc. news releases on 6ix. Latest, Mar 31, 2022: Aadi Bioscience Announces First Patient Dosed in its PRECISION 1 Phase 2…
Press releases — page 3
Aadi Bioscience Announces First Patient Dosed in its PRECISION 1 Phase 2 Registrational Trial of nab-Sirolimus in Patients with Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 and TSC2 Genes
March 30, 2022
Aadi Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
March 16, 2022
Aadi Bioscience to Participate in Panel Discussion on Tumor-Agnostic Development at Cowen’s 42nd Annual Health Care Conference
February 28, 2022
Aadi Bioscience Announces U.S. Commercial Launch and Availability of FYARRO™ for the Treatment of Adult Patients with Locally Advanced Unresectable or Metastatic Malignant PEComa
February 22, 2022
Aadi Bioscience to Present at 2022 H.C. Wainwright BioConnect Virtual Conference
January 3, 2022
Aadi Bioscience to Participate in Upcoming Investor Conferences
November 8, 2021